Intracoronary radiation to treat in-stent restenosis in six cardiac transplant patients

Catheter Cardiovasc Interv. 2003 Sep;60(1):41-4. doi: 10.1002/ccd.10607.

Abstract

Transplant vasculopathy significantly limits the survival of cardiac transplant patients and occurs in 50% of patients by 5 years posttransplant. We report our experience with six cardiac transplant patients who underwent intracoronary brachytherapy for in-stent restenosis. At four centers, six patients underwent intracoronary radiation for in-stent restenosis. All patients received extended antiplatelet therapy with clopidogrel and aspirin. Follow-up angiography was performed in all patients. Two of the six patients underwent subsequent target lesion revascularization. Patient 1 presented with total occlusion of her radiated lesion. She had a complex procedure requiring stenting for a dissection after the radiation dwell. Patient 2 had high-grade restenosis following brachytherapy. Patient 3 had a 50% restenotic lesion. Patients 4, 5, and 6 had follow-up angiography that showed no evidence of restenosis. There are few good options to treated accelerated transplant vasculopathy. Radiation therapy may be a viable option in this difficult patient population.

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use
  • Arteries / pathology
  • Arteries / radiation effects
  • Arteries / surgery
  • Aspirin / therapeutic use
  • Blood Vessel Prosthesis Implantation
  • Brachytherapy*
  • California
  • Clopidogrel
  • Coronary Angiography
  • Coronary Restenosis / diagnosis
  • Coronary Restenosis / radiotherapy
  • Coronary Restenosis / therapy*
  • Coronary Vessels / pathology
  • Coronary Vessels / radiation effects
  • Coronary Vessels / surgery
  • Female
  • Follow-Up Studies
  • Heart Transplantation*
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use
  • Reoperation
  • Stents*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin
  • Abciximab